Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults With Acute Myeloid Leukaemia and Myelodysplastic Syndrome

Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes Interventions: Drug: idarubicin; Drug: Cytarabine Sponsors: First Affiliated Hospital of Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials